about
Intestinal microbiota in human health and disease: the impact of probioticsDysbiosis in inflammatory bowel diseaseAssessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous floraThe role of antibiotics and probiotics in pouchitisWhat are the effects of proton pump inhibitors on the small intestine?Consistent metagenomic biomarker detection via robust PCA.Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis.A meta-analysis of probiotic efficacy for gastrointestinal diseasesAssessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA).Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens.Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli.Do probiotics have a therapeutic role in gastroenterology?Probiotics in infective diarrhoea and inflammatory bowel diseases.Probiotics and prebiotics in chronic inflammatory bowel diseases.The bowel microbiota and inflammatory bowel diseases.Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii.Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration.The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis.Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis.Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisEffects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition.Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosidesPostoperative Crohn's disease.Butyrate increases IL-23 production by stimulated dendritic cells.Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitisProbiotics in clinical practice: an overview.Analysis of bacterial bowel communities of IBD patients: what has it revealed?Diet of patients after pouch surgery may affect pouch inflammation.Laboratory tests for patients with ileal pouch-anal anastomosis: clinical utility in predicting, diagnosing, and monitoring pouch disorders.The bacterial pathogenesis and treatment of pouchitis.Etiology of pouchitis.Probiotics for the treatment of inflammatory bowel disease.Bacteriology in the etiopathogenesis of pouchitis.The emerging therapeutic role of probiotics in inflammatory bowel disease.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis.Reliable Biomarker discovery from Metagenomic data via RegLRSD algorithm.Review article: the pathogenesis of pouchitis.
P2860
Q24628739-D67E3637-8E39-4B89-B6B5-85896FC08AC9Q24685931-B8103C2D-F3D4-4452-8E59-FEE7AA17B72EQ24791618-C361EDE4-1B44-461F-97FC-A73F76F8CDF9Q27000314-A345FC15-98A2-40CF-9460-C9B4042D4A6FQ28263539-AD2CBC51-8D8A-4E06-9CA8-7992CF7316B3Q30836964-E36B545A-6758-4737-85DC-9D9B49B7A4D3Q30927782-9D8CEAE4-23DB-42F7-ADDB-990524931E27Q31057363-A4C80827-1541-4796-93D9-4F7CEEA1EA6FQ33212468-6E3DAE02-EFD2-4948-AFB5-9D5F3921772BQ33231186-696F1554-D38B-4D15-87D0-AAB0D21FC7DAQ33290058-011FB9B6-8C0A-464F-BA4C-8782D3DF365AQ33868113-15C21C5A-4B60-47D2-82A5-D512458EA387Q33869477-566DDFB6-FEF7-4CC3-BE3F-C9E6F974CB97Q33939743-8A8F4B57-FA4C-4FBD-A70F-074F2074150DQ34013030-B3CE5A6B-D10D-430F-8717-2F79E76C33D5Q34415209-CB961F3E-1911-43CB-8025-0259D458799EQ34472684-889A1641-04CB-4541-95F9-FCF22AEF0F64Q34523427-A135E6F2-1F99-46EF-A826-2745E4B8BEFDQ34955775-2EE62644-DD7A-40F0-BF1D-52BB0DAA15D7Q35594644-190F2EEE-7FB2-40AD-A3A5-CF046221F007Q35596222-31952900-7226-48FF-A1B9-EBEAF9F97E3AQ35621330-B3362851-9D90-4555-B217-ACCC97C17E69Q35950044-C1175D82-D691-484A-804C-495BC9D8D12DQ36207261-CB3CEB98-B0F7-445D-AB36-EE5185AADE79Q36494684-6ABC4CDB-7F92-451C-878D-47E3A32FBD73Q36497063-C4475C90-AEBC-407D-A3E6-DB33228A5E5EQ37071265-7A0F609D-3D2D-4D31-A600-1181E26BC539Q37084765-FEB45934-10A5-4D1A-BCCD-192CBF5F5117Q37241528-3A4D3488-75AC-469B-84D9-3AF6BE0BC776Q37551596-0991171D-C1AD-472B-9863-24050FEF2819Q37823330-017A80B4-5C95-4229-9DEF-60F32A571D36Q37948714-C44DEA5B-38DB-4210-9BD8-9E4BDB554118Q38009716-4CD3F520-FEAC-492D-B8D1-093DE45E7C39Q38026393-8116B1AB-166A-4F5A-B170-1FF756292385Q38026552-09DA3E36-FA75-4089-8601-270410C0E890Q38049779-89CBF185-FD40-4101-BB11-E9A2A0F8B8CEQ38442953-2F01A5DF-53BA-425B-B824-1F6ABA90E6E0Q38552422-AB07CE9E-2136-4B1E-A13A-0238EB605462Q38685888-F7A262AC-661D-4AF2-AA52-80F294167B7BQ38828436-3CFDC7E2-6413-4930-852C-1318D0295C38
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Pouchitis: result of microbial imbalance?
@ast
Pouchitis: result of microbial imbalance?
@en
Pouchitis: result of microbial imbalance?
@nl
type
label
Pouchitis: result of microbial imbalance?
@ast
Pouchitis: result of microbial imbalance?
@en
Pouchitis: result of microbial imbalance?
@nl
prefLabel
Pouchitis: result of microbial imbalance?
@ast
Pouchitis: result of microbial imbalance?
@en
Pouchitis: result of microbial imbalance?
@nl
P2093
P2860
P356
P1433
P1476
Pouchitis: result of microbial imbalance?
@en
P2093
Ruseler-van Embden JG
Schouten WR
van Lieshout LM
P2860
P304
P356
10.1136/GUT.35.5.658
P407
P577
1994-05-01T00:00:00Z